Stanford Cancer Institute Palo Alto — Palo Alto, California

Stanford Cancer Institute Palo Alto is a clinical research site located in Palo Alto, California, United States 94304.

Crixeo Clinical Trials Trust Score: 34/100 (FAILING). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute Palo Alto has participated in 202 clinical trials with 121 currently active.

Therapeutic areas: Breast Carcinoma, Estrogen Receptor Positive, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8.

Sponsors: Andrei Iagaru, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Palo Alto

Browse all research sites in California · View every site in Palo Alto

• Stanford University Medical Centre
• VA Palo Alto Health Care System, NC-PTSD, Dissemination and Training Division
• Stanford University Hospital and Medical Center
• Stanford University Medical Center CTRU - 800 Welch Road
• Lucile Packard Children's Hospital & Stanford Hospital
• VA Palo Alto - Cardiac Catheterization Laboratory
• Stanford University School of Medicine, Dermatology Department
• Lucile Packard Children's Hospital Stanford
• Palo Alto Veterans Affairs Hospital System
• Stanford University Clinical and Translational Research Unit
• Stanford University VA
• Stanford University School of Medicine Center for Academic Medicine

Sponsor Feasibility Report

Trust Score: 34/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute Palo Alto?

Stanford Cancer Institute Palo Alto has a Crixeo Trust Score of 34/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute Palo Alto conducted?

Stanford Cancer Institute Palo Alto has 202 clinical trials on record, with 121 currently active. Their work covers Breast Carcinoma, Estrogen Receptor Positive, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8.

Is Stanford Cancer Institute Palo Alto accredited by Crixeo Clinical Trials?

Stanford Cancer Institute Palo Alto has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute Palo Alto?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.